Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension



Rating:

Share or cite this content

Citations should be made in the following way:
M. Arkani (Amsterdam, Netherlands), S. Jansen (Amsterdam, Netherlands), S. In'T Veld (Amsterdam, Netherlands), J. Smits (Amsterdam, Netherlands), E. Post (Amsterdam, Netherlands), K. Zwaan (Amsterdam, Netherlands), J. Ramaker (Amsterdam, Netherlands), F. S. De Man (Amsterdam, Netherlands), A. Vonk Noordegraaf (Amsterdam, Netherlands), M. Best (Amsterdam, Netherlands), T. Wurdinger (Amsterdam, Netherlands), H. Bogaard (Amsterdam, Netherlands). mRNA sequencing of educated platelets generates a diagnostic biomarker for discrimination between pre- and post-capillary pulmonary hypertension.. 1526

Member's Comments

No comment yet.

Related content which might interest you: Differential expression of miRNAs present in plasma and contained within circulating microparticles in precapillary pulmonary hypertension. Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 A point-of-care brain natriuretic peptide assay in the risk stratification and management of patients with pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 48s Year: 2006 Impact of the state of endothelium on clinical and functional parameters in COPD patients with arterial hypertension. Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Differential diagnosis of pre- and post-capillary pulmonary hypertension: the OPTICS study and other strategies Source: Virtual Congress 2021 – Pulmonary vascular diseases Year: 2021 Proteomic profiling identifies an exercise signature in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Circulating collagen biomarker and quality of life in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010 The use of non-invasive stroke volume measurement to assess treatment response in pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Circulating endothelial cell levels decrease after vasodilator therapy and are a biomarker of clinical worsening in refractory pulmonary hypertension in children Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 A novel echo-score for evaluating the pre-test probability of pre-capillary versus post-capillary pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: end-points and biomarkers Year: 2012 Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis Source: Eur Respir J 2013; 41: 1324-1330 Year: 2013 Expression of fetal genes in pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms Year: 2005 Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 RNA expression pattern of peripheral blood B-lymphocytes in idiopathic pulmonary arterial hypertension Source: Annual Congress 2007 - Pathogenesis and novel therapeutic targets in pulmonary hypertension Year: 2007 Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Dipyridamole as adjuvant therapy in patients with pulmonary arterial hypertension. A pilot study Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment Year: 2007 NT-proBNP variation in stable pulmonary arterial hypertension patients. Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 The comparison of diagnostic relevance of protein C, C-reactive protein and endothelin-1 for prediction of lung vessel thrombosis in patients with community-acquired pneumonia Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019 Cardiopulmonary exercise testing for detection of early pulmonary vascular changes in relatives of patients with idiopathic pulmonary arterial hypertension Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension Year: 2007